GSK

#123
GSK plc American Depositary Shares (Each representing two Ordinary Shares)
57.7050 USD
-0.22%
Setor: Cuidados de saúde
Base: USD
Moeda do lucro: USD
Faixa diária
57.5900
57.7700
Faixa anual
42.8850
61.6950
Mudança diária
-0.22%
Mudança mensal
+7.37%
Mudança em 6 meses
+31.60%
Mudança anual
+31.60%
Fechamento anterior
57.8300
Abrir
57.7100
Bid
Ask
Mínimo
57.5900
High
57.7700
Volume
202
Abrir gráfico completo

Financials

Visão geral Relatórios Estatísticas Dividendos
Trimestral Ano
Demonstração de resultados Balanço patrimonial Fluxo de caixa
Valor Q4, 24Q4, 25 TTM

GSK plc American Depositary Shares (Each representing two Ordin

GSK plc is a British multinational pharmaceutical and biotechnology company. It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm. It is headquartered in London, England. GSK is the tenth-largest pharmaceutical company in the world by earnings, $9.32 billion in 2025 with $42.4 billion in revenues in the same period. As of February 2026 it is the 175th most valuable company in the world and the 12th most valuable pharmaceutical company with a market capitalisation of $122.6 billion. It was also ranked 388th on the 2025 Fortune Global 500. The company has a primary listing on the London Stock Exchange and is a constituent of the FTSE 100 Index, the eighth largest on the London Stock Exchange behind British pharmaceutical rival AstraZeneca, which occupies the No 1 spot in London at a value of $325 billion, 2.7x more than GSK. The company developed the first malaria vaccine, RTS, S, which it said in 2014, it would make available for five per cent above cost.

Notícias